Wuhan Keqian Biology Co.,Ltd.’s Net Profit Rose 20.7% in First Three Quarters of 2021

Wuhan Keqian Biology Co.,Ltd. (武汉科前生物股份有限公司) (688526.SH) reported a net profit of 385.9 million yuan in the first three quarters of 2021, up 20.7% year-on-year.
Meanwhile, the company posted 775.7 million yuan in revenue, up 28.4% year-on-year.
At the end of the reporting period, it had 3.6 billion yuan in total assets and 680.4 million yuan in total liabilities, with a liability-to-asset ratio of 18.7%.
This article was automatically produced by Caixin Automation on Nov. 3, 2021.
Download our app to receive breaking news alerts and read the news on the go.
Follow the Chinese markets in real time with Caixin Global’s new stock database.
- PODCAST
- MOST POPULAR